Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine

Pain Medicine

Volumn 8, Issue 1, 2007, Pages 65-70

  García Leiva, Juan M ^a   Hidalgo, Javier ^a   Rico Villademoros, Fernando ^a   Moreno, Vicente ^b   Calandre, Elena P ^a,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Anesthetic Injection; Migraine; Prophylactic Management; Referred Pain; Trigger Points

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; GLUCOCORTICOID; NEUROLEPTIC AGENT; PIZOTIFEN; ROPIVACAINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; TEMPORALIS MUSCLE; TRIGGER POINT;

ADOLESCENT; ADULT; AGED; AMIDES; ANESTHETICS, LOCAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MYOFASCIAL PAIN SYNDROMES; PAIN, REFERRED;

EID: 33846371199     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2007.00251.x     Document Type: Article

References (24)

1. Jensen K, Tuxen C, Olesen J. Pericranial muscle tenderness and pressure-pain threshold in temporal region during common migraine. Pain 1988;35:65-70.
2. Jensen K. Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies. Acta Neurol Scand 1993;147(suppl):1-27.
3. Anttila P, Metsähonkala L, Mikkelsson M, et al. Muscle tenderness in pericranial and neck-shoulder region in children with headache. A controlled study. Cephalalgia 2002;22:340-4.
4. Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991;46:125-32.
5. Kidd RF, Nelson R. Musculoskeletal dysfunction of the neck in migraine and tension headache. Headache 1993;33:563-9.
6. Calandre EP, Hidalgo J, Garcia-Leiva JM, Rico-Villademoros F. Trigger point evaluation in migraine patients: An indication of peripheral sensitization linked to migraine predisposition? Eur J Neurol 2006;13:244-9.
7. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000;123:1703-9.
8. Tfelt-Hansen P, Lous I, Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache 1982;21:49-54.
9. Hesse J, Møgelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: A randomized trial of trigger point inactivation. J Intern Med 1994;235:451-6.
10. Mellick GA, Mellick LB. Regional head and face pain relief following lower cervical intramuscular anesthetic injection. Headache 2003;43:1109-11.
11. Young WB, Mateos V, Ashkenazi A. Occipital nerve block rapidly eliminates allodynia far from the site of headache: A case report. Cephalalgia 2004;24:906-7.
12. Brown BR. Diagnosis and therapy of common myofascial syndromes. JAMA 1978;239:646-8.
13. Frost FA, Jessen B, Sigaard-Andersen J. A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain. Lancet 1980;1:499-500.
14. Frost A. Diclofenac versus lidocaine as injection therapy in myofascial pain. Scand J Rheumatol 1986;15:153-6.
15. Esenyel M, Caglar N, Aldemir T. Treatment of myofascial pain. Am J Phys Med Rehabil 2000;79:48-52.
16. Criscuolo CM. Interventional approaches to the management of myofascial pain syndrome. Curr Pain Headache Rep 2001;5:407-11.
17. Alvarez DJ, Rockwell PG. Trigger points: Diagnosis and management. Am Fam Physician 2002;65:653-60.
18. Baldry P. Management of myofascial trigger point pain. Acupunct Med 2002;20:2-10.
19. Borg-Stein J, Stein J. Trigger points and tender points. One and the same? Does injection treatment help? Rheum Dis Clin North Am 1996;22:305-22.
20. Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth 1997;22:89-101.
21. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004;24(suppl1):1-150.
22. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Department Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976: 179-222.
23. Granston A, Drummond PD. Painful stimulation of the temple during optokinetic stimulation triggers migraine-like attacks in migraine sufferers. Cephalalgia 2005;25:219-24.
24. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001;89(2-3):107-10.